Shiva Hosseinian

Shiva Hosseinian

Auto-generated profile, based on publicly available information

Shiva Hosseinian

Iran University of Medical Sciences

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2026 in Research Square
Verified
Preprint
Open access
PDF file
AGAmir Ghadipasha
Amir Ghadipasha
MMMohammad Mehrnia
Mohammad Mehrnia
SHShiva Hosseinian
Shiva Hosseinian
SVSara Vafadar
Sara Vafadar
ZHZahra Hosseinzade
Zahra Hosseinzade
NMNegin Mousaeinejad
Negin Mousaeinejad
Background Acute kidney injury (AKI) is a frequent and serious complication in pediatric intensive care units (PICUs), and early detection is limited by delayed creatinine-based criteria. Machine learning (ML) using electronic health record (EHR) data may improve early risk prediction. Objective To develop and evaluate an explainable Extreme Gradient Boosting (XGBoost) model for early AKI prediction in a general PICU population and compare its performance with the Renal Angina Index (RAI). Methods This retrospective study included 513 children aged 1–18 years admitted to two tertiary PICUs between 2011 and 2023. AKI was defined by KDIGO serum creatinine criteria. Routinely collected clinical, laboratory, ventilatory, and medication variables recorded prior to AKI onset were used. Model performance was assessed using accuracy, sensitivity, F1-score, AUROC, and net reclassification improvement (NRI). Results The ML model achieved an AUROC of 0.888 with accuracy 0.742, outperforming RAI (AUROC 0.470). NRI favored the ML model (0.504). Key predictors included serum creatinine measures, hemoglobin, and mean arterial pressure. Conclusions An explainable XGBoost model accurately predicted AKI in critically ill children and substantially outperformed RAI, supporting its use for early PICU risk stratification.

12 October 2025 in Journal of Renal Injury Prevention
Verified
Journal Article
Open access
Sina Salem AhimSina Salem Ahim
Sina Salem Ahim
SHShiva Hosseinian
Shiva Hosseinian
SBSalehoddin Bouya
Salehoddin Bouya
PHParham Habiby
Parham Habiby
MMMaryam Miri
Maryam Miri
RARasoul Jafari Arismani
Rasoul Jafari Arismani
World Kidney Day (WKD), established in 2006, marks a pivotal milestone in 2026 as it celebrates its 20th anniversary. This event was first observed on March 9, 2006, as a joint initiative of the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations (IFKF), now known as the International Kidney Foundation – World kidney alliance (IKF-WKA). The primary objective was to raise global awareness about the increasing burden of kidney diseases and to promote preventive behaviors and equitable access to care. Since its inception, WKD has grown into a powerful global movement, celebrated annually on the second Thursday of March by several countries across six continents. As WKD approaches its 20th anniversary in 2026, it offers a timely opportunity to reflect on two decades of achievements, challenges, and lessons learned. Over the past two decades, WKD has evolved from a modest awareness initiative into a globally recognized health campaign, uniting healthcare professionals, policymakers, and patient advocacy groups in the efforts against kidney disease. Finally, this event highlights the importance of addressing chronic kidney disease through awareness, prevention, screening, and comprehensive management to improve outcomes and reduce the global health burden of kidney disease.

28 February 2026 in Journal of Renal Injury Prevention
Verified
Journal Article
Closed access
Sina Salem AhimSina Salem Ahim
Sina Salem Ahim
AMA. Mokhtariardekani
A. Mokhtariardekani
HSH. Sanadgol
H. Sanadgol
SHS. Hosseinian
S. Hosseinian
MSM. SalekShahabi
M. SalekShahabi
ZMZ. Hamidi Madani
Z. Hamidi Madani
Insulin resistance in polycystic ovary syndrome (PCOS) contributes to renal dysfunction through multiple interconnected mechanisms. In PCOS, insulin resistance leads to compensatory hyperinsulinemia, which exacerbates metabolic disturbances including hyperandrogenism and systemic inflammation. These factors collectively promote renal injury. Meanwhile, insulin resistance in PCOS promotes hypertension and endothelial dysfunction, which impair renal microcirculation. Hyperinsulinemia increases sodium retention and activates the renin-angiotensin-aldosterone system (RAAS), further elevating blood pressure and causing glomerular hyperfiltration and damage. Insulin resistance also contributes to dyslipidemia and oxidative stress, accelerating atherosclerosis and renal vascular injury. Moreover, insulin resistance worsens hyperuricemia by reducing renal uric acid excretion, which is a direct nephrotoxic factor. Persistent hyperuricemia leads to inflammation and fibrosis within the kidneys, potentially progressing to chronic kidney disease (CKD). In addition, systemic low-grade inflammation and oxidative stress driven by insulin resistance and PCOS-related hyperandrogenism also induce renal tissue injury through inflammatory cytokines and apoptotic pathways, contributing to impairment in renal function.

1 June 2025 in Journal of Surgery and Trauma
Verified
Journal Article
Open access
PDF file
SDSeyedamir Tabibzadeh Dezfooli
Seyedamir Tabibzadeh Dezfooli
SHShiva Hosseinian
Shiva Hosseinian
MMMehdi Mohammadi
Mehdi Mohammadi
AJAlireza Javan
Alireza Javan
NMNegin Mousaeinejad
Negin Mousaeinejad
HEHamidreza Khoshnezhad Ebrahimi
Hamidreza Khoshnezhad Ebrahimi
Introduction: Trauma is one of the leading causes of death and disability in societies, with traffic accidents being the most significant cause of mortality among traumas. Injuries resulting from road traffic accidents are a major public health issue that requires continuous and effective monitoring and coordination, given the emergencies associated with ...